For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260324:nRSX7799Xa&default-theme=true
RNS Number : 7799X Clean Power Hydrogen PLC 24 March 2026
24 March 2026
Clean Power Hydrogen plc
("CPH2" or the "Company")
Memorandum of Understanding with Siemens plc
CPH2 (AIM:CPH2), which has developed market disrupting and IP-protected
Membrane-Free Electrolyser ("MFE") technology for the production of commercial
high purity hydrogen and above medical-grade purity oxygen, announces that it
has entered into a non-binding Memorandum of Understanding ("MOU") with
Siemens plc. It is the intention of Siemens and CPH2 to conclude a legally
binding agreement in relation to Siemens assisting CPH2 across a range of
activities focussed on successfully scaling up CPH2's MFE production and
maintaining its technology leadership.
Further updates in respect of the progress towards a legally binding agreement
between the parties will follow in due course.
Commenting, Chief Executive Officer of CPH2, Jon Duffy, said: "Our discussions
with Siemens cover a range of activities from enhanced process and automation
to customer introduction, marketing, 24/7 technical support, training, joint
product and process development and Go-to-Market strategies, all with the
objective to upscale CPH2 production. We look forward to updating the Market
further on this in due course."
ENDS
Enquiries:
Clean Power Hydrogen via Square1 Consulting
Jon Duffy, Chief Executive Officer
James Hobson, Chief Financial Officer
Cavendish Capital Markets Limited - NOMAD & Joint Broker
Neil McDonald +44 131 220 9771
Peter Lynch +44 131 220 9772
Turner Pope Investments (TPI) Limited - Joint Broker
Andy Thacker/Guy McDougall +44 203 657 0050
Square1 Consulting Limited
David Bick +44 7831 381201
Background on CPH2
CPH2 is the holding company of Clean Power Hydrogen Group Limited which has a
decade of dedicated research and product development experience that has
delivered global patents in breakthrough hydrogen and oxygen production
technology. The Group's strategic objective is to deliver the lowest lifetime
Levelised Cost of Hydrogen ("LCOH") in the market in relation to the
production of hydrogen at this scale. CPH2 is listed on the AIM market and
trades under the ticker LSE: CPH2.
For more information: https://www.cph2.com (https://www.cph2.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END AGRJJMBTMTATTJF
Copyright 2019 Regulatory News Service, all rights reserved